issues with glp 1 Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society - Whether you've seen the buzz
Description
Todd Sohn, Strategas ETF & Technical Strategist, also joins the conversation.
GLP-1
p=0.030) and 25% higher at 12 months (95% CI: 2 to 59
After revolutionizing care for diabetes and weight loss, GLP-1 drugs are being eyed for more
As patients in regions like New York City increasingly seek weight management solutions, it's essential to understand how this medication might affect oral health
Learn why it happens, common symptoms, and practical ways to manage it with safe, expert-backed guidance.
